
Mercury Bio offers Mercury RNA Delivery Platform
Biomolecular RNA delivery platform targeting specific cells and organs including across the blood-brain barrier.
- Currently Offered

Biomolecular RNA delivery platform targeting specific cells and organs including across the blood-brain barrier.
Mercury Bio's biomolecular advanced drug delivery system delivers natural-like RNA molecules to specific cells and organs, with a patented yEV technology demonstrating functional delivery of therapeutic cargo into neurons across the blood-brain barrier while avoiding endosomal entrapment.
The non-LNP platform targets neurodegenerative conditions such as Parkinson's and Alzheimer's disease alongside viral disease, cancer, and inflammatory programs.


Aptamer delivery platform for tissue-specific delivery of RNA payloads including siRNA, ASO, and LNPs.


STELLAR is Copernicus Therapeutics' non-viral gene delivery platform for compacted DNA nanoparticles.
Aptamer delivery platform for tissue-specific delivery of RNA payloads including siRNA, ASO, and LNPs.

STELLAR is Copernicus Therapeutics' non-viral gene delivery platform for compacted DNA nanoparticles.



Wholly-owned preclinical RNA therapy pipeline across immunology, CNS, and neuromuscular disease.


Antibody-oligonucleotide conjugate platform delivering siRNA and PMO payloads to muscle, cardiac, and immune cells.


Selective organ-targeting lipid nanoparticle platform for genetic medicine delivery beyond the liver.



AI-guided cyclic-oligonucleotide platform for designing ASO, siRNA, and sgRNA drug candidates.
Wholly-owned preclinical RNA therapy pipeline across immunology, CNS, and neuromuscular disease.

Antibody-oligonucleotide conjugate platform delivering siRNA and PMO payloads to muscle, cardiac, and immune cells.

Selective organ-targeting lipid nanoparticle platform for genetic medicine delivery beyond the liver.

Nonviral ultrasound-mediated platform delivering DNA and RNA payloads to targeted tissues using microbubble enhancing agents.

AI-guided cyclic-oligonucleotide platform for designing ASO, siRNA, and sgRNA drug candidates.
